Trusted advisor on 80+ product launches worldwide
Launch 3x Faster and Avoid $1M+ in Delays with Rob’s Medtech Playbook
Cut launch delays, fix adoption gaps, and avoid 6-figure waste with Rob's proven frameworks used by top medtech teams when the margin for error is zero.
$1.5M Saved in Product Cost Waste
12 Weeks Average Launch Time Saved
80+ Medical Products Guided to Market
45% Increase in Eligible Patients Reached
[email protected]
(XXX) XXX-XXXX
Meet Robert Miraglia – 20+ Years of Clarity, Alignment, and Execution
Robert Miraglia is a strategic product leader and launch advisor with a proven track record across medical device, pharmaceutical, and managed healthcare sectors. His rare combination of clinical insight, market strategy, and commercial execution has earned him a reputation as the go-to consultant when launch timelines tighten, adoption stalls, or cross-functional teams are out of sync.
From negotiating $1.5M in vendor savings to leading 80+ product evaluations, Rob doesn’t just advise—he engineers clarity at scale.
Social Proof Section (Stats, testimonials, Case Studies, etc.)
Social Proof
DATA-DRIVEN. PHYSICIAN-READY
Avoid 6-Figure Launch Misfires With Upstream Strategy That Aligns Teams
Rob identifies misalignment early across research, positioning, and stakeholder input so that your product launches with clarity, confidence, and cross-functional buy-in.
CLINICALLY INFORMED. COMMERCIALLY PROVEN.
Turn Clinical Insight Into Strategy That Wins Market Share
Rob blends KOL interviews, segmentation, and evidence-based messaging so products land with speed, proof, and precision.
BACKED BY 80+ PRODUCT EVALUATIONS
De-Risk Every Product Bet With Proven Market Insight
Robert applies data-driven segmentation and VoC analysis so that your roadmap reflects real market demand, not assumptions.
Social Proof Section (Stats, testimonials, Case Studies, etc.)
Social Proof
Go-to-Market Clarity That Blends Science, Strategy, and Execution with Robert Miraglia
Product Evaluation & Concept Vetting
Rob assesses market potential, technical viability, and regulatory risks for new product concepts—giving companies a data-backed greenlight (or red flag) before investing millions.
Clinical & Market Research for Product Strategy
Rob designs and runs in-depth interviews with KOLs, compiles competitor dossiers, conducts segmentation/targeting, and translates findings into strategic marketing plans.
Upstream Portfolio Strategy & Roadmapping
Rob leads product roadmapping based on unmet needs, market sizing, and feasibility. He’s directly influenced multimillion-dollar product direction (e.g., DCBs, IVL, EPDs) using segmentation, forecasting, and cross-functional influence.
Voice-of-Customer (VoC) Development & KOL Management
Rob builds clinical credibility and commercial traction through relationships with key opinion leaders. He designs and executes VoC programs that shape product requirements and messaging that resonate.
Pricing, Forecasting & Financial Modeling
Rob’s strategies around pricing tiers, cost modeling, and forecasting have driven 30%+ gross margin gains and multimillion-dollar launches. His financial analysis informs smarter product decisions from day one.
Cross-Functional Commercial Strategy Alignment
Rob leads alignment across R&D, Clinical, Marketing, and Sales—preventing the common disconnects that derail launches. He’s the translator between product complexity and market success.
What Teams Like Yours Always Ask Before Saying Yes
What types of companies do you typically work with?
I primarily work with medical device companies. This includes early-stage startups preparing for their first product launch as well as established global manufacturers looking to refine their commercial strategy. Whether you’re entering the market or scaling an existing portfolio, I help teams find the clearest path forward and avoid costly missteps.
What’s your experience with launch planning and execution?
I’ve led or supported over 30 medical device launches across product categories including imaging, infection control, vascular intervention, and diagnostics. My clients rely on me to not just build launch plans—but to see around corners, flag risks early, and build scalable go-to-market systems.
Do you only work with U.S.-based companies?
While I’m based in Long Island, New York, I’ve worked with teams across North America and Europe. As long as we’re aligned on goals and communication, I can support clients remotely or on-site for critical milestones like launch planning, field team alignment, or investor decks.
What’s your process like?
Every engagement starts with a discovery phase to understand your goals, team structure, timelines, and where friction may be slowing you down. From there, I provide a tailored scope of work. That could mean high-level strategy sessions or hands-on support with product launches. I stay focused on speed, fit, and return on investment.
How do we know this investment will pay off?
My work has helped clients avoid $10M+ in wasted spend and reduce time-to-launch by 30% or more. If you’re making decisions that affect regulatory risk, market share, or product adoption, the cost of misalignment is far greater than the cost of getting it right.
Trusted advisor on 80+ product launches worldwide
Get Expert Eyes on Your Launch Before It’s Too Late
Every delay, misstep, or stall costs you real revenue. A 15-minute strategy call could shift the outcome.
$1.5M Saved in Product Cost Waste
12 Weeks Average Launch Time Saved
80+ Medical Products Guided to Market
45% Increase in Eligible Patients Reached
Copyright 2025. Rubicon Med. All Rights Reserved.